FBXO22 is a potential therapeutic target for recurrent chondrosarcoma.
Xin B, Chen H, Zhu Z, Guan Q, Bai G, Yang C, Zou W, Gao X, Li L, Liu T.
Xin B, et al. Among authors: liu t.
J Bone Oncol. 2024 May 1;46:100605. doi: 10.1016/j.jbo.2024.100605. eCollection 2024 Jun.
J Bone Oncol. 2024.
PMID: 38742151
Free PMC article.